{
  "issued_date": "2010-03-23", 
  "original_url": "http://www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON076289", 
  "doc_details": {
    "Type": "Medical Device Alert", 
    "Series No": "MDA/2010/023", 
    "Audience": "Healthcare professionals", 
    "Published": "23 March 2010 at 14:30", 
    "Format": "Electronic only", 
    "Size": "A4", 
    "Pages": "4", 
    "Price": "Free", 
    "ISBN/ISSN": "", 
    "Author": "", 
    "Copyright": "Crown"
  }, 
  "_assets": [
    {
      "content_type": "image/jpeg", 
      "title": "Intracranial stent: SILK artery reconstruction device manufactured by Balt Extrusion and distributed in the UK by Pyramed Ltd.", 
      "assetid": 0, 
      "original_url": "http://www.mhra.gov.uk/idcm2/groups/dts-bs/documents/medicaldevicealert/con076305.jpg", 
      "filename": "downloads/1c16cfeb202f9984a74d45de2e6c79874541f5e2/con076305.jpg", 
      "original_filename": "con076305.jpg"
    }, 
    {
      "content_type": "image/jpeg", 
      "title": "SILK artery reconstruction device manufactured by Balt Extrusion and distributed in the UK by Pyramed Ltd.", 
      "assetid": 1, 
      "original_url": "http://www.mhra.gov.uk/idcm2/groups/dts-bs/documents/medicaldevicealert/con076306.jpg", 
      "filename": "downloads/0eb8a6b292c40f18befe52e1fffde9c6daf6add9/con076306.jpg", 
      "original_filename": "con076306.jpg"
    }
  ], 
  "body": "## Device\n\n![ASSET_TAG](#ASSET0)\n\nIntracranial stent: SILK artery reconstruction device manufactured by Balt Extrusion and distributed in the UK by Pyramed Ltd.\n\nAll SILK artery reconstruction devices are affected by this notice.\n\nThis device is indicated for treating tracranial aneurysms.\n\n![ASSET_TAG](#ASSET1)\n\n\u00a0\n\n## Problem\n\nPotential for patient death if the device is used to treat intracranial aneurysms without using embolisation coils.\n\nThe MHRA is aware of reports of patient deaths (including four in the UK) associated with the use of the SILK device. These fatalities occurred between 5 and 150 days after implantation.\n\nThe causes of these deaths have not been conclusively determined. However, each of these patients had been treated for an existing large (15 to 25mm) or giant (25 to 50mm) intracranial aneurysm and without the use of additional embolisation coils.\n\nThe manufacturer (Balt Extrusion, France) issued an urgent [Field Safety Notice on 09 March 2010](http://www.mhra.gov.uk/home/ssLINK/CON076109) advising that it does not currently have the clinical data to support the use of the SILK device without the use of embolisation coils.\n\nThe manufacturer now intends to amend the instructions for use (IFU) to reflect this advice. It is also planning a post-market clinical trial to investigate the use of the SILK device without coils in aneurysms with a diameter less than 15mm.\n\n## Action\n\nDo not use the SILK device without embolisation coils.\n\nIdentify patients who have been implanted with the SILK device without embolisation coils and:  \n  \n  * assess the status of the aneurysm at approximately 3 months post implant by a non-invasive technique eg CTA/MRA  \n  * assess the status of the aneurysm at approximately 6 months post implant by an invasive technique eg angiography  \n  * insert a further stent if the aneurysm status is unsatisfactory at these times.  \n  \n## Distribution\n\nThis MDA has been distributed to:  \n  \n  * NHS trusts in England (Chief Executives)  \n  * HSC trusts in Northern Ireland (Chief Executives)  \n  * NHS boards in Scotland (Chief Executives)  \n  * NHS boards and trusts in Wales (Chief Executives)  \n  \nOnward distribution  \nPlease bring this notice to the attention of all who need to know or be aware of it. This may include distribution by:  \n  \nTrusts to:  \nCAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:  \n  \n  * clinical governance leads  \n  * heads of radiology  \n  * interventional neuroradiologists  \n  * medical directors  \n  * neurologists  \n  * neurosurgeons  \n  * purchasing managers  \n  * risk managers  \n  * supplies managers  \n  * theatre managers  \n  * theatres  \n  \nCare Quality Commission (CQC) (England only) to:  \nThe MHRA considers this information to be important to:  \n  \n  * hospitals in the independent sector  \n  * independent treatment centres  \n  * private medical practitioners  \n  \n## Manufacturer Contact\n\nSupplier  \nClive Noel Pyramed Ltd.  \nUnitech House  \nUnit B1-B2  \nBond Close  \nKingsland Business Park  \nBasingstoke  \nHampshire  \nRG24 8PZ\n\nTel: 01256 365 454  \nFax: 01256 365 486\n\nEmail: [clive.noel@pyramed.co.uk](mailto:clive.noel@pyramed.co.uk)\n\nManufacturer  \nEric Largen  \nBalt Extrusion  \n10 rue de la Croix Vigneron  \n95160 Montmorency  \nFrance\n\nTel: +33 139 34 61 84  \nFax: +33 134 17 03 46\n\nEmail: [quality.manager@balt.fr](mailto:quality.manager@balt.fr)\n\n## Feedback\n\nIf you have any comments or feedback on this Medical Device Alert, please email us at: [dts@mhra.gsi.gov.uk](mailto:dts@mhra.gsi.gov.uk)\u00a0\n\n## England\n\nIf you are in England, please send enquiries about this notice to the MHRA, quoting reference number MDA/2010/023 or 2009/012/003/401/010\u00a0\n\nTechnical aspects  \nClare Huntington or Sarah Debenham  \nMedicines & Healthcare products Regulatory Agency  \nMarket Towers  \n1 Nine Elms Lane  \nLondon  \nSW8 5NQ  \n  \nTel: 020 7084 3163/3264  \nFax: 020 7084 3106  \n  \nEmail: [clare.huntington@mhra.gsi.gov.uk](mailto:clare.huntington@mhra.gsi.gov.uk)\u00a0or [sarah.debenham@mhra.gsi.gov.uk](mailto:sarah.debenham@mhra.gsi.gov.uk)\n\nClinical aspects  \nDr Susanne Ludgate  \nMedicines & Healthcare products Regulatory Agency  \nMarket Towers  \n1 Nine Elms Lane  \nLondon  \nSW8 5NQ  \n  \nTel: 020 7084 3123  \nFax: 020 7084 3111  \n  \nEmail: [susanne.ludgate@mhra.gsi.gov.uk](mailto:susanne.ludgate@mhra.gsi.gov.uk)  \n  \nHow to report adverse incidents  \nPlease report via our website: [Reporting adverse incidents involving medical devices](http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/index.htm).  \nFurther information about CAS can be found on the [Central Alerting System website](https://www.cas.dh.gov.uk/Home.aspx) (external link).\n\n## Northern Ireland\n\nAlerts in Northern Ireland will continue to be distributed via the NI SABS system.\n\nEnquiries and adverse incident reports in Northern Ireland should be addressed to:\n\nNorthern Ireland Adverse Incident Centre  \nHealth Estates Investment Group  \nRoom 17  \nAnnex 6  \nCastle Buildings  \nStormont Estate  \nDundonald  \nBT4 3SQ\n\nTel: 02890 523 704  \nFax: 02890 523 900\n\nEmail: [NIAIC@dhsspsni.gov.uk](mailto:NIAIC@dhsspsni.gov.uk)  \n  \n[Northern Ireland Adverse Incident Centre (NIAIC)](http://www.dhsspsni.gov.uk/index/hea/niaic.htm) (external link)\n\nHow to report adverse incidents in Northern Ireland  \nPlease report directly to NIAIC, further information can be found on the [NIAIC website](http://www.dhsspsni.gov.uk/niaic) (external link).  \nFurther information about SABS can be found on the [SABS website](http://sabs.dhsspsni.gov.uk/) (external link).\n\n## Scotland\n\nEnquiries and adverse incident reports in Scotland should be addressed to:\n\nIncident Reporting and Investigation Centre  \nHealth Facilities Scotland  \nNHS National Services Scotland  \nGyle Square  \n1 South Gyle Crescent  \nEdinburgh  \nEH12 9EB\n\nTel: 0131 275 7575  \nFax: 0131 314 0722\n\nEmail: [nss.iric@nhs.net](mailto:nss.iric@nhs.net)\n\n[Health Facilities Scotland - Incident Reporting and Investigation Centre](http://www.hfs.scot.nhs.uk/online-services/incident-reporting-and-investigation-centre-iric/) (external link).\n\n## Wales\n\nEnquiries in Wales should be addressed to:\n\nDr Sara Hayes  \nSenior Medical Officer  \nMedical Device Alerts  \nWelsh Assembly Government  \nCathays Park  \nCardiff  \nCF10 3NQ\n\nTel: 029 2082 3922\n\nEmail: [Haz-Aic@wales.gsi.gov.uk](mailto:Haz-Aic@wales.gsi.gov.uk)\n", 
  "raw_html": "<div id=\"inner_tab_content\">\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n\t\t\r\n\t\t\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t<h2 class=\"sw\">Device</h2><div class=\"content_section active_content_section\" id=\"Device\">\r\n\t\t\t\t\t\t\t\t<p><span><font class=\"imageright\"><img src=\"#ASSET0\" alt=\"ASSET_TAG\"></font></span></p><p><span>Intracranial stent: SILK artery reconstruction device manufactured by Balt Extrusion and distributed in the UK by Pyramed Ltd.</span></p><p>All SILK artery reconstruction devices are affected by this notice.</p><p>This device is indicated for treating tracranial aneurysms.</p><img src=\"#ASSET1\" alt=\"ASSET_TAG\"><p>&#160;</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Problem</h2><div class=\"content_section\" id=\"Problem\">\r\n\t\t\t\t\t\t\t\t<p><span>Potential for patient death if the device is used to treat intracranial aneurysms without using embolisation coils.</span></p><p>The MHRA is aware of reports of patient deaths (including four in the UK) associated with the use of the SILK device. These fatalities occurred between 5 and 150 days after implantation.</p><p>The causes of these deaths have not been conclusively determined. However, each of these patients had been treated for an existing large (15 to 25mm) or giant (25 to 50mm) intracranial aneurysm and without the use of additional embolisation coils.</p><p>The manufacturer (Balt Extrusion, France) issued an urgent <a href=\"http://www.mhra.gov.uk/home/ssLINK/CON076109\">Field Safety Notice on 09 March 2010</a> advising that it does not currently have the clinical data to support the use of the SILK device without the use of embolisation coils.</p><p>The manufacturer now intends to amend the instructions for use (IFU) to reflect this advice. It is also planning a post-market clinical trial to investigate the use of the SILK device without coils in aneurysms with a diameter less than 15mm.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Action</h2><div class=\"content_section\" id=\"Action\">\r\n\t\t\t\t\t\t\t\t<p>Do not use the SILK device without embolisation coils.</p><p>Identify patients who have been implanted with the SILK device without embolisation coils and:</p><ul>\r\n\t\t\t\t<li>assess the status of the aneurysm at approximately 3 months post implant by a non-invasive technique eg CTA/MRA</li>\r\n\t\t\t\t<li>assess the status of the aneurysm at approximately 6 months post implant by an invasive technique eg angiography</li>\r\n\t\t\t\t<li>insert a further stent if the aneurysm status is unsatisfactory at these times.</li></ul>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Distribution</h2><div class=\"content_section\" id=\"Distribution\">\r\n\t\t\t\t\t\t\t\t<p>This MDA has been distributed to:</p><ul>\r\n\t\t\t\t<li>NHS trusts in England (Chief Executives)</li>\r\n\t\t\t\t<li>HSC trusts in Northern Ireland (Chief Executives)</li>\r\n\t\t\t\t<li>NHS boards in Scotland (Chief Executives)</li>\r\n\t\t\t\t<li>NHS boards and trusts in Wales (Chief Executives)</li></ul><p><font class=\"h3\">Onward distribution<br></font> Please bring this notice to the attention of all who need to know or be aware of it. This may include distribution by:<br><br><font class=\"h4\">Trusts to:</font><br>CAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:</p><ul>\r\n\t\t\t\t<li>clinical governance leads</li>\r\n\t\t\t\t<li>heads of radiology</li>\r\n\t\t\t\t<li>interventional neuroradiologists</li>\r\n\t\t\t\t<li>medical directors</li>\r\n\t\t\t\t<li>neurologists</li>\r\n\t\t\t\t<li>neurosurgeons</li>\r\n\t\t\t\t<li>purchasing managers</li>\r\n\t\t\t\t<li>risk managers</li>\r\n\t\t\t\t<li>supplies managers</li>\r\n\t\t\t\t<li>theatre managers</li>\r\n\t\t\t\t<li>theatres</li></ul><p><font class=\"h4\">Care Quality Commission (CQC) (England only) to:<br></font> The MHRA considers this information to be important to:</p><ul>\r\n\t\t\t\t<li>hospitals in the independent sector</li>\r\n\t\t\t\t<li>independent treatment centres</li>\r\n\t\t\t\t<li>private medical practitioners</li></ul>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Manufacturer Contact</h2><div class=\"content_section\" id=\"Manufacturer Contact\">\r\n\t\t\t\t\t\t\t\t<p><font class=\"h4\">Supplier</font><br>Clive Noel Pyramed Ltd.<br>Unitech House<br>Unit B1-B2<br>Bond Close<br>Kingsland Business Park<br>Basingstoke<br>Hampshire<br>RG24 8PZ</p><p>Tel: 01256 365 454<br>Fax: 01256 365 486</p><p>Email: <a href=\"mailto:clive.noel@pyramed.co.uk\">clive.noel@pyramed.co.uk</a></p><p><font class=\"h4\">Manufacturer</font><br>Eric Largen<br>Balt Extrusion<br>10 rue de la Croix Vigneron<br>95160 Montmorency<br>France</p><p>Tel: +33 139 34 61 84<br>Fax: +33 134 17 03 46</p><p>Email: <a href=\"mailto:quality.manager@balt.fr\">quality.manager@balt.fr</a></p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Feedback</h2><div class=\"content_section\" id=\"Feedback\">\r\n\t\t\t\t\t\t\t\t<p>If you have any comments or feedback on this Medical Device Alert, please email us at: <a href=\"mailto:dts@mhra.gsi.gov.uk\">dts@mhra.gsi.gov.uk</a>&#160;</p>\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t<h2 class=\"sw\">England</h2><div class=\"content_section\" id=\"England\">\r\n\t\t\t\t\t\t\t\t\t<p>If you are in England, please send enquiries about this notice to the MHRA, quoting reference number <span>MDA/2010/023</span> or <span>2009/012/003/401/010</span>&#160;</p><p><span>Technical aspects</span><br>Clare Huntington or Sarah Debenham<br>Medicines &amp; Healthcare products Regulatory Agency<br>Market Towers<br>1 Nine Elms Lane<br>London<br>SW8 5NQ<br><br>Tel: 020 7084 3163/3264<br>Fax: 020 7084 3106<br><br>Email: <a href=\"mailto:clare.huntington@mhra.gsi.gov.uk\">clare.huntington@mhra.gsi.gov.uk</a>&#160;or <a href=\"mailto:sarah.debenham@mhra.gsi.gov.uk\">sarah.debenham@mhra.gsi.gov.uk</a></p><p><span>Clinical aspects</span><br>Dr Susanne Ludgate<br>Medicines &amp; Healthcare products Regulatory Agency<br>Market Towers<br>1 Nine Elms Lane<br>London<br>SW8 5NQ<br><br>Tel: 020 7084 3123<br>Fax: 020 7084 3111<br><br>Email: <a href=\"mailto:susanne.ludgate@mhra.gsi.gov.uk\">susanne.ludgate@mhra.gsi.gov.uk</a><br><br><font class=\"h3\">How to report adverse incidents<br></font>Please report via our website: <a href=\"http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/index.htm\">Reporting adverse incidents involving medical devices</a>.<br>Further information about CAS can be found on the <a href=\"https://www.cas.dh.gov.uk/Home.aspx\" target=\"_blank\">Central Alerting System website</a> (external link).</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Northern Ireland</h2><div class=\"content_section\" id=\"Northern Ireland\">\r\n\t\t\t\t\t\t\t\t\t<p>Alerts in Northern Ireland will continue to be distributed via the NI SABS system.</p><p>Enquiries and adverse incident reports in Northern Ireland should be addressed to:</p><p>Northern Ireland Adverse Incident Centre<br>Health Estates Investment Group<br>Room 17<br>Annex 6<br>Castle Buildings<br>Stormont Estate<br>Dundonald<br>BT4 3SQ</p><p>Tel: 02890 523 704<br>Fax: 02890 523 900</p><p>Email: <a href=\"mailto:NIAIC@dhsspsni.gov.uk\">NIAIC@dhsspsni.gov.uk</a><br><br><a href=\"http://www.dhsspsni.gov.uk/index/hea/niaic.htm\" target=\"_blank\">Northern Ireland Adverse Incident Centre (NIAIC)</a> (external link)</p><p><font class=\"h3\">How to report adverse incidents in Northern Ireland<br></font> Please report directly to NIAIC, further information can be found on the <a href=\"http://www.dhsspsni.gov.uk/niaic\" target=\"_blank\">NIAIC website</a> (external link).<br>Further information about SABS can be found on the <a href=\"http://sabs.dhsspsni.gov.uk/\" target=\"_blank\">SABS website</a> (external link).</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Scotland</h2><div class=\"content_section\" id=\"Scotland\">\r\n\t\t\t\t\t\t\t\t\t<p>Enquiries and adverse incident reports in Scotland should be addressed to:</p><p>Incident Reporting and Investigation Centre<br>Health Facilities Scotland<br>NHS National Services Scotland<br>Gyle Square<br>1 South Gyle Crescent<br>Edinburgh<br>EH12 9EB</p><p>Tel: 0131 275 7575<br>Fax: 0131 314 0722</p><p>Email: <a href=\"mailto:nss.iric@nhs.net\">nss.iric@nhs.net</a></p><p><a href=\"http://www.hfs.scot.nhs.uk/online-services/incident-reporting-and-investigation-centre-iric/\" target=\"_blank\">Health Facilities Scotland - Incident Reporting and Investigation Centre</a> (external link).</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Wales</h2><div class=\"content_section\" id=\"Wales\">\r\n\t\t\t\t\t\t\t\t\t<p>Enquiries in Wales should be addressed to:</p><p>Dr Sara Hayes<br>Senior Medical Officer<br>Medical Device Alerts<br>Welsh Assembly Government<br>Cathays Park<br>Cardiff<br>CF10 3NQ</p><p>Tel: 029 2082 3922</p><p>Email: <a href=\"mailto:Haz-Aic@wales.gsi.gov.uk\">Haz-Aic@wales.gsi.gov.uk</a></p>\r\n\t\t\t\t\t\t\t\t</div>\r\n</div>\r\n\t\t\t", 
  "title": "Medical Device Alert: Intracranial stent manufactured by Balt Extrusion (MDA/2010/023)", 
  "alert_type": [
    "devices"
  ], 
  "medical_specialism": []
}